V4c
Development of a new generation of pediatric mRNA vaccins, capable of activating cytological T cells against the four serotypes of dengue virus, thus preventing the risk of Antibody Dependent Enhancement (ADE).
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at V4c
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at V4c
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at V4c
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.